CYTOKINETICS INC Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2014 to Q2 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Cytokinetics Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2014 to Q2 2024.
- Cytokinetics Inc Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $24.6M, a 31.9% increase year-over-year.
- Cytokinetics Inc Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $84.4M, a 39.5% increase year-over-year.
- Cytokinetics Inc annual Share-based Payment Arrangement, Expense for 2023 was $72.1M, a 50.6% increase from 2022.
- Cytokinetics Inc annual Share-based Payment Arrangement, Expense for 2022 was $47.9M, a 78.3% increase from 2021.
- Cytokinetics Inc annual Share-based Payment Arrangement, Expense for 2021 was $26.8M, a 52.3% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)